Appetite Suppressants and Valvular Heart Disease

@article{Weissman2001AppetiteSA,
  title={Appetite Suppressants and Valvular Heart Disease},
  author={N. Weissman},
  journal={The American Journal of the Medical Sciences},
  year={2001},
  volume={321},
  pages={285-291}
}
  • N. Weissman
  • Published 2001
  • Medicine
  • The American Journal of the Medical Sciences
  • The association between valvular heart disease and diet pills was discovered several years ago in a small cohort of patients. Subsequent uncontrolled surveys and reports suggested a prevalence of cardiac abnormalities as high as 30%. These results led to widespread concern by millions of appetite suppressant users and the withdrawal of both fenfluramine and dexfenfluramine from the market. Through this review of the literature, it becomes apparent that we have better defined the association… CONTINUE READING
    44 Citations
    Pulmonary Hypertension Associated with Use of Phentermine
    • 5
    Drug-induced heart failure.
    • Carleton B Maxwell, A. T. Jenkins
    • Medicine
    • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
    • 2011
    • 19
    Pharmacotherapy of obesity.
    • N. Finer
    • Medicine
    • Best practice & research. Clinical endocrinology & metabolism
    • 2002
    • 59
    Cardiac valvulopathy associated with pergolide use.
    • C. Zadikoff, P. Rochon, A. Lang
    • Medicine
    • The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
    • 2006
    • 27
    • PDF
    Recent and Future Drugs for the Treatment of Obesity
    • 7
    • PDF

    References

    SHOWING 1-10 OF 27 REFERENCES
    Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota.
    • 21